From GNBT Twitter: “With the launch of our su
Post# of 36537
“With the launch of our subsidiary's new website, nugenerexio.com, we have dedicated a large portion of the site to further explain how our Ii-key #vaccine technology platform is applied in cancer and infectious diseases like triple-negative breast cancer and #COVID19.”